Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javid Fazili

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Gastroenterology|April 16, 2008
Fluvastatin inhibits hepatitis C replication in humansTed Bader, Javid Fazili, Mohammed Madhoun, et al.
Gastroenterology Research and Practice|July 9, 2019
Treatment Outcomes of Hepatitis C-Infected Patients in Specialty Clinic vs. Primary Care Physician Clinic: A Comparative AnalysisTaseen Ahmed Syed, Muhammad Hassaan Bashir, Samid Muhammad Farooqui, et al.
The American Journal of Gastroenterology|October 19, 2002
Development and validation of a model to diagnose cirrhosis in patients with hepatitis CVivek Kaul, Frank K Friedenberg, Leonard E Braitman, et al.
Digestive Diseases and Sciences|April 23, 2010
Outcome of a hepatitis C outbreak among patients in a pain management clinicJavid Fazili, Sue Mallonee, William M Tierney, et al.
Oncotarget|October 16, 2015
Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanismSripathi M Sureban, Mohammad F Madhoun, Randal May, et al.
International Journal of Molecular Sciences|June 27, 2024
From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver DiseasesLandon L Moore, Dongfeng Qu, Sripathi Sureban, et al.
Scientific Reports|July 1, 2020
Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanismNaushad Ali, Charles B Nguyen, Parthasarathy Chandrakesan, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The American Journal of Gastroenterology|April 16, 2008
Fluvastatin inhibits hepatitis C replication in humansTed Bader, Javid Fazili, Mohammed Madhoun, et al.
Gastroenterology Research and Practice|July 9, 2019
Treatment Outcomes of Hepatitis C-Infected Patients in Specialty Clinic vs. Primary Care Physician Clinic: A Comparative AnalysisTaseen Ahmed Syed, Muhammad Hassaan Bashir, Samid Muhammad Farooqui, et al.
The American Journal of Gastroenterology|October 19, 2002
Development and validation of a model to diagnose cirrhosis in patients with hepatitis CVivek Kaul, Frank K Friedenberg, Leonard E Braitman, et al.
Digestive Diseases and Sciences|April 23, 2010
Outcome of a hepatitis C outbreak among patients in a pain management clinicJavid Fazili, Sue Mallonee, William M Tierney, et al.
Oncotarget|October 16, 2015
Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanismSripathi M Sureban, Mohammad F Madhoun, Randal May, et al.
International Journal of Molecular Sciences|June 27, 2024
From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver DiseasesLandon L Moore, Dongfeng Qu, Sripathi Sureban, et al.
Scientific Reports|July 1, 2020
Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanismNaushad Ali, Charles B Nguyen, Parthasarathy Chandrakesan, et al.
Pageof 2